PLOD1 and amenorrhea: The outcomes considered were (i) the number of cases of abnormal spermatogenesis, abnormal testosterone secretion (low serum testosterone and/or elevated LH levels); (ii) the number of cases of secondary (transient, permanent) amenorrhea; iii) the number of patients reporting symptoms of estrogen deprivation.